Clinical Trial Update: Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating safety and efficacy of luliconazole 1% cream in pediatric participants with Tinea Corporis; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis

Drugs mentioned

• Luliconazole Cream 1% (luliconazole)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Tinea Corporis | Phase 4 | Status: COMPLETED | Results posted: 2019-11-27